Comparative effectiveness of therapies for clinically localized prostate cancer

This report summarizes evidence comparing the relative effectiveness and safety of treatment options for clinically localized prostate cancer. The report addresses the following questions: 1) What are the comparative risks, benefits, short- and long-term outcomes of therapies for clinically localize...

Full description

Main Author: Wilt, Timothy J.
Corporate Authors: United States Agency for Healthcare Research and Quality, Minnesota Evidence-based Practice Center
Format: eBook
Language:English
Published: [Rockville, MD Agency for Healthcare Research and Quality 2008, 2008]
Series:Comparative effectiveness review
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Summary:This report summarizes evidence comparing the relative effectiveness and safety of treatment options for clinically localized prostate cancer. The report addresses the following questions: 1) What are the comparative risks, benefits, short- and long-term outcomes of therapies for clinically localized prostate cancer? 2) How do specific patient characteristics, e.g., age, race/ethnicity, presence or absence of comorbid illness, preferences (e.g., tradeoff of treatment-related adverse effects vs. potential for disease progression), affect the outcomes of these therapies, overall and differentially? 3) How do provider/hospital characteristics affect outcomes overall and differentially (e.g., geographic region and volume)? 4) How do tumor characteristics, e.g., Gleason score, tumor volume, screen vs. clinically detected tumors, affect the outcomes of these therapies, overall and differentially?
Item Description:Title from PDF t.p. (viewed Aug. 30, 2011). - "February 2008.". - "Contract no. 290-02-0009."
Physical Description:1 PDF file (1 v. (various pagings ill.)